A comparison of outcomes between concurrent chemoradiotherapy and radiotherapy alone in cancer of the uterine cervix: a single institutional experience

被引:0
作者
Byun, S. J. [1 ]
Kim, J. H. [1 ]
Kim, O. B. [1 ]
Oh, Y. K. [1 ]
Cho, C. H. [2 ,3 ]
机构
[1] Keimyung Univ, Dongsan Med Ctr, Dept Radiat Oncol, Taegu 700712, South Korea
[2] Keimyung Univ, Dongsan Med Ctr, Dept Obstet, Taegu 700712, South Korea
[3] Keimyung Univ, Dongsan Med Ctr, Dept Gynecol, Taegu 700712, South Korea
关键词
Uterine cervical neoplasm; Concurrent chemoradiotherapy; Radiotherapy; Treatment outcome; Prognosis; GYNECOLOGIC-ONCOLOGY-GROUP; SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; DIABETES-MELLITUS; DEFINITIVE RADIOTHERAPY; HEMOGLOBIN LEVELS; PELVIC RADIATION; PHASE-II; CHEMOTHERAPY; STAGE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To compare failure patterns and evaluate prognostic factors related to survival rates after concurrent chemoradiotherapy (CCRT) or radiotherapy (RT) alone in cervical cancer. Materials and Methods: From January 1996 to December 2006, 218 patients with cervical cancer (FIGO Stage IB2 - III) treated with CCRT or RT alone as primary treatments were included, retrospectively. One-hundred eight patients were treated with CCRT and 110 with RT alone. Results: There was no significant difference in failure patterns between the treatment groups, but distant metastasis was the predominant pattern in both groups. The frequent metastatic sites were supraclavicular lymph node, lung, and brain. Treatment group, diabetes, and FIGO Stage were found to be significant for overall survival (OS) and disease-free survival (DFS), and initial hemoglobin level for DFS. Conclusion: Distant metastasis is the predominant failure pattern and diabetes is one of the independent prognostic factors to survival rates in this study.
引用
收藏
页码:402 / 408
页数:7
相关论文
共 41 条
[1]   Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer [J].
Caudle, A. S. ;
Kim, H. J. ;
Tepper, J. E. ;
O'Neil, B. H. ;
Lange, L. A. ;
Goldberg, R. M. ;
Bernard, S. A. ;
Calvo, B. F. ;
Meyers, M. O. .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (07) :1931-1936
[2]   Anemia in cervical cancers: Impact on survival, patterns of relapse, and association with hypoxia and angiogenesis [J].
Dunst, J ;
Kuhnt, T ;
Strauss, HG ;
Krause, U ;
Pelz, T ;
Koelbl, H ;
Haensgen, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (03) :778-787
[3]  
EIFEL PJ, 1990, CANCER-AM CANCER SOC, V65, P2507, DOI 10.1002/1097-0142(19900601)65:11<2507::AID-CNCR2820651120>3.0.CO
[4]  
2-9
[5]   THE INFLUENCE OF TUMOR SIZE AND MORPHOLOGY ON THE OUTCOME OF PATIENTS WITH FIGO STAGE IB SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX [J].
EIFEL, PJ ;
MORRIS, M ;
WHARTON, JT ;
OSWALD, MJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (01) :9-16
[6]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247
[7]   Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis [J].
Green, JA ;
Kirwan, JM ;
Tierney, JF ;
Symonds, P ;
Fresco, L ;
Collingwood, M ;
Williams, CJ .
LANCET, 2001, 358 (9284) :781-786
[8]  
Grogan M, 1999, CANCER-AM CANCER SOC, V86, P1528, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO
[9]  
2-E
[10]   Impact of tumor hypoxia and anemia on radiation therapy outcomes [J].
Harrison, LB ;
Chadha, M ;
Hill, RJ ;
Hu, K ;
Shasha, D .
ONCOLOGIST, 2002, 7 (06) :492-508